Showing results (111-120 of 163) with videos related to

Sort By:
Pageof 17
The Journal of Thoracic and Cardiovascular Surgery|July 7, 2005
Acute hemodynamic effects of restrictive mitral annuloplasty in patients with end-stage heart failure: analysis by pressure-volume relationsSven A F Tulner, Paul Steendijk, Robert J M Klautz, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 18, 2013
Heart disease in the Netherlands: a quantitative updateM J G Leening, S Siregar, I Vaartjes, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 29, 2006
Long-term survival after non-small cell lung cancer surgery: development and validation of a prognostic model with a preoperative and postoperative modeOzcan Birim, A Pieter Kappetein, Marco Waleboer, et al.
QJM : Monthly Journal of the Association of Physicians|January 29, 2016
A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysemaJ Stolk, W Broekman, T Mauad, et al.
Journal of Cardiovascular Computed Tomography|November 7, 2016
Prognostic implications of descending thoracic aorta dilation after surgery for aortic dissectionMadelien V Regeer, Bryan Martina, Michel I M Versteegh, et al.
Health and Quality of Life Outcomes|July 22, 2020
Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness modelMira D Franken, Anne de Hond, Koen Degeling, et al.
Journal of Cardiology|June 5, 2018
Long-term results of mitral valve repair for severe mitral regurgitation in asymptomatic patientsAnton Tomšič, Yasmine L Hiemstra, Fabienne M A van Hout, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 17, 2019
Risk factors and clinical significance of elevated mitral valve gradient following valve repair for degenerative diseaseAnton Tomšič, Yasmine L Hiemstra, Bardia Arabkhani, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands: A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic GuidelinesIsaac Corro Ramos, Matthijs M Versteegh, Rudolf A de Boer, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 18, 2020
Summarizing Patient Preferences for the Competitive Landscape of Multiple Sclerosis Treatment OptionsMarcel F Jonker, Bas Donkers, Lucas M A Goossens, et al.
Pageof 17